http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
2019 대한부정맥학회 경피적심혈관중재술을 받는 심방세동 환자에서 항응고 치료 지침
황유미 ( You Mi Hwang ),이지현 ( Ji Hyun Lee ),이기홍 ( Ki Hong Lee ),임우현 ( Woo-hyun Lim ),심재민 ( Jaemin Shim ),이영수 ( Young Soo Lee ),박진규 ( Jin-kyu Park ),김태훈 ( Tae-hoon Kim ),김준 ( Jun Kim ),정보영 ( Boyoung Joung 대한내과학회 2019 대한내과학회지 Vol.94 No.4
The choice of an adequate antithrombotic regimen for atrial fibrillation patients undergoing emergent or elective percutaneous coronary intervention (PCI) should be based on the ischemic event and on the risk of bleeding. Recent randomized controlled trials have consistently demonstrated that dual antithrombotic therapeutic regimens, using non-vitamin K anticoagulants and clopidogrel, are superior to triple or dual therapy with warfarin and aspirin. This report incorporates findings of recent notable studies to provide concrete, clinically useful details and recommendations for bleeding risk assessment and optimal antithrombotic therapeutic strategies after PCI. In addition, we introduce guidelines for antithrombotic management after structural heart disease intervention. (Korean J Med 2019;94:330-342)
2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: 처방의 시작과 유지
박진규 ( Jin-kyu Park ),김준 ( Jun Kim ),백용수 ( Yong Soo Baek ),이소령 ( So-ryoung Lee ),황유미 ( You Mi Hwang ),김태훈 ( Tae-hoon Kim ),이대인 ( Dae In Lee ),이기홍 ( Ki Hong Lee ),심재민 ( Jaemin Shim ),정보영 ( Boyoung Joung 대한내과학회 2019 대한내과학회지 Vol.94 No.1
Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists to prevent stroke in patients with non-valvular atrial fibrillation (AF) and have emerged as the preferred choice. The use of NOACs is rapidly increasing in Korea after coverage by insurance since 2015. However, the rate of prescribing anticoagulants in Korean patients with AF remains low compared to other countries. Most of the NOAC anticoagulant prescriptions are issued at hospitals. As the prevalence rate of AF in Korea is expected to increase rapidly with the increase in the elderly population, the need to prescribe NOACs in primary care clinics will also increase. Therefore, The Korean Heart Rhythm Society organized the Korean Atrial Fibrillation Management Guideline Committee and analyzed all available studies based on the 2018 European Heart Rhythm Association Practical Guide on the use of NOACs for managing AF, as well as studies on Korean patients. The authors would like to introduce practical guidelines for NOAC prescriptions in Korean patients with AF. (Korean J Med 2019;94:17-39)